Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2001 Feb;45(2):624-6.
doi: 10.1128/AAC.45.2.624-626.2001.

In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancer

F Alcaide  1 , M A Benítez, J Carratalà, F Gudiol, J Liñares, R Martín
Affiliations
Comparative Study

In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancer

F Alcaide et al. Antimicrob Agents Chemother. 2001 Feb.

Abstract

The in vitro activities of the ketolide telithromycin and eight other antibiotics were tested against 77 strains of viridans group streptococci isolated from blood samples of neutropenic patients. Thirty-one (40.3%) of the strains were resistant to penicillin G, and 27 (35.1%) were resistant to erythromycin A. Telithromycin (MIC range of < or =0.03 to 1 microg/ml) was the most active antimicrobial tested. These data suggest that telithromycin could be useful for treatment of viridans group streptococcal bacteremia in neutropenic patients with cancer.

PubMed Disclaimer

References

    1. Alcaide F, Liñares J, Pallares R, Carratala J, Benitez M A, Gudiol F, Martin R. In vitro activities of 22 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother. 1995;39:2243–2247. - PMC - PubMed
    1. Alcaide F, Carratala J, Liñares J, Gudiol F, Martin R. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrob Agents Chemother. 1996;40:2117–2120. - PMC - PubMed
    1. Awada A, Van der Auwera P, Meunier P, Daneau D, Klastersky J. Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis. 1992;15:33–48. - PubMed
    1. Barry A L, Fuchs P C, Brown S D. In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae. Antimicrob Agents Chemother. 1998;42:2138–2140. - PMC - PubMed
    1. Bilgrami S, Feingold J M, Dorsky D, Edwards R L, Clive J, Tutschka P J. Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1998;21:591–595. - PubMed

Publication types